Figure 3.
Figure 3. Cumulative incidence of aGVHD grade B-D in related donors (A; n = 3191) and URDs (B; n = 2370) stratified by treatment category. The analysis was performed through the CIBMTR. PBSC indicates peripheral blood stem cell. Reprinted with permission from Jagasia et al.4

Cumulative incidence of aGVHD grade B-D in related donors (A; n = 3191) and URDs (B; n = 2370) stratified by treatment category. The analysis was performed through the CIBMTR. PBSC indicates peripheral blood stem cell. Reprinted with permission from Jagasia et al.

Close Modal

or Create an Account

Close Modal
Close Modal